Atopia Therapeutics Appoints Dr. Grégoire Chevalier As Chief Executive Officer
05/07/24, 2:12 PM
Location
Industry
therapeutics
biotechnology
health care
Position
chief executive officer
Atopia Therapeutics, formerly known as HpVac, has appointed Dr. Grégoire Chevalier as the new chief executive officer (CEO). The company has repositioned itself to better reflect its commitment to addressing the growing global burden of atopic diseases.
Company Info
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Dh
Dh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more